NewsBur
No Result
View All Result
Saturday, January 16, 2021
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
Subscribe
Newsbur
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
No Result
View All Result
Newsbur
No Result
View All Result
Home Market News

Onconova Therapeutics Inc [ONTX] In a Perfect Setup for a Bullish Pullback

by Nick Brown
September 21, 2020
in Market News, Trending Stocks
0
Why Apple Inc [AAPL] Stock Is Still Undervalued with Current Market Cap of 1.9 Trillion?
0
SHARES
28
VIEWS
Share on FacebookShare on Twitter

Onconova Therapeutics Inc [NASDAQ:ONTX] took a beating in August following a cancer study that failed to meet its primary endpoints. At the time, the stock opened with a gap down that is yet to be close. Despite the drop and the continued low prices, this stocks holds lots of opportunities for growth in the near-term. There are several factors that play in this stock’s potential value growth. Some of the key value drivers for this stock are as below:

The fundamentals are strong

Despite the price drop after the failed cancer study, the company continued to invest in research and development. As such, it stands to gain in value once those investments start to bear fruit. Like all other biotech stocks, The Company engages in scientific research and development and there are times when research does not bear fruit and there are times when it things go right. In the context of Onconova, a breakthrough in its next research could see the stock rocket in the near-term. The company already stated that it is working on a project for lung adenocarcinoma. When announcing the failed cancer study, it stated that it would be focusing its energies on an investigator initiated study program for oral rigosertib beyond its current phase I/IIa in KRAS and lung adenocarcinoma, in solid tumors. If the company records a breakthrough on this front, it could see its value touch new highs and recover all the losses from the past two months.

The stock is trading at a key support level

After the company announced that its trial for cancer had failed, the stock value dropped to a key support level around the $0.32 range. Essentially this means that it is trading at a point of maximum pain and has little room to drop any further. This means that any good news are likely to put upside pressure on the stock. This is evident in its recent price action when the company announced that its CEO was presenting at several key investor conferences. So far there are a number of positive factors that could help push this stock up in the near-term.  One of them is a COVID-19 vaccine that would uplift the stock markets as a whole. In such a scenario, stocks that offer maximum gains such as ONTX could rally more than the rest of the market.

About Onconova Therapeutics Inc

Onconova Therapeutics Inc is a biopharma company that develops cancer treatments. It is based in Newton, Pennsylvania.

Tags: NASDAQ:ONTXONTXONTX stock

Recommended Stories

Boston Scientific Corporation [NYSE:BSX]’s prices rallied on Friday.

August 25, 2020

Credit Suisse High Yield Bond Fund Inc. [DHY] is One of the Best Plays in Financial and This Proves It

September 16, 2020

Ceridian HCM Holding Inc. [CDAY] is One of the Best Plays in Technology and This Proves It

August 26, 2020

Popular Stories

  • Sorrento Therapeutics Inc. [SRNE] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] Is Skyrocketing 13.15% on Pure Fundamentals

    0 shares
    Share 0 Tweet 0
  • BlackBerry Limited [BB] is a Top Ten Buy with Quarterly Revenues of 999.00M

    0 shares
    Share 0 Tweet 0
  • Impressive Profit Margins of -5.80% Raise Bull Flags for General Electric Company [GE]

    0 shares
    Share 0 Tweet 0

NewsBur.com

Newsbur.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Recent Posts

  • After-Hours Trading Alert: Amgen Inc. [AMGN] is Up 0.85% After the Bell
  • Has Dynatrace Inc. [DT] Completely Outpaced Other Companies in the Technology This Year?
  • Why Applied Materials Inc. [AMAT]’s 1.55% Drop is No Cause for Alarm

Categories

  • Analyst Actions
  • Market News
  • Morning News
  • Trending Stocks
  • Uncategorized

© 2020 Copyright © All Rights Reserved.

No Result
View All Result
  • Home
  • Market News
  • Morning News
  • Analyst Actions
  • Trending Stocks

© 2020 Copyright © All Rights Reserved.